咽頭がん治療法の世界市場:咽頭がん、喉頭がん

◆英語タイトル:Global Throat Cancer Therapeutics Market 2019-2023
◆商品コード:IRTNTR31383
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年5月27日
◆ページ数:125
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、咽頭がん治療法の世界市場について調べ、咽頭がん治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、咽頭がん治療法の市場規模をセグメンテーション別(種類別(咽頭がん、喉頭がん))と地域別(グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ))に分けて算出しました。
・サマリー
・レポートの範囲
・咽頭がん治療法の市場状況
・咽頭がん治療法の市場規模
・咽頭がん治療法の市場予測
・咽頭がん治療法の世界環境:ファイブフォース分析
・市場セグメンテーション:種類別(咽頭がん、喉頭がん)
・咽頭がん治療法の顧客状況
・主要地域別市場規模:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Throat Cancer Therapeutics Market: About this market

Throat cancer is a type of head and neck cancer that affects the tissues in the pharynx or the larynx. Technavio’s throat cancer treatment market analysis considers the treatment of pharyngeal cancer and laryngeal cancer. Our analysis also considers the treatment of throat cancer in Asia, Europe, North America, and South America. In 2018, the pharyngeal cancer segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as changing lifestyle will play a significant role in the pharyngeal cancer segment to maintain its market position. Also, our global throat cancer therapeutics market looks at factors such as increasing incidence of throat cancer, increasing the use of tobacco products, and increasing risk factors. However, the preference for alternative treatment options, severe adverse effects, and high treatment cost may hamper the growth of the throat cancer therapeutics industry over the forecast period.

Global Throat Cancer Therapeutics Market: Overview

Increasing incidence of throat cancer

The global throat cancer treatment market has witnessed an increase in the number of throat cancer cases despite advancements in the R&D of therapeutics. The condition is increasingly becoming prevalent in countries across Europe, Asia, and North America. In the US, the mortality rate for the condition increased from 2.5 deaths per every 100,000 people to 2.6 deaths per every 100,000 people over the past decade. The increasing prevalence of throat cancer has increased the number of awareness campaigns to aid in the early diagnosis of the condition. The increasing incidence of throat cancer is one of the major factors driving the growth of the global throat cancer therapeutics market at a CAGR of nearly 7% over the forecast period.

Strong pipeline

The increasing prevalence of throat cancer has encouraged many large and mid-sized vendors to conduct R&Ds to develop novel drugs for the condition. Many vendors in the market have developed novel therapies that are in the late stages of clinical trials for the treatment of various head and neck cancer indications, including pharyngeal and laryngeal cancer. These developments among vendors are expected to fuel the growth of the global throat cancer therapeutics market size.

For the detailed list of factors that will drive global cancer therapeutics market size during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few players, the global throat cancer therapeutics market is fairly concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several throat cancer therapeutics companies, that include Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Sanofi.

Also, the throat cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE

Market segmentation by type

Comparison by type

Pharyngeal cancer – Market size and forecast 2018-2023

Laryngeal cancer – Market size and forecast 2018-2023

Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Bristol-Myers Squibb Co.

Eli Lilly and Co.

F. Hoffmann-La Roche Ltd.

Merck & Co., Inc.

Sanofi

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global oncology therapeutics market

Exhibit 02: Segments of global oncology therapeutics market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Global throat cancer therapeutics market pipeline: Overview

Exhibit 18: Global throat cancer therapeutics market pipeline: Snapshot

Exhibit 19: Type – Market share 2018-2023 (%)

Exhibit 20: Comparison by type

Exhibit 21: Pharyngeal cancer – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Pharyngeal cancer – Year-over-year growth 2019-2023 (%)

Exhibit 23: Laryngeal cancer – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Laryngeal cancer – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by type

Exhibit 26: Customer landscape

Exhibit 27: Market share by geography 2018-2023 (%)

Exhibit 28: Geographic comparison

Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: North America – Year-over-year growth 2019-2023 (%)

Exhibit 31: Top 3 countries in North America

Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 34: Top 3 countries in Europe

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 37: Top 3 countries in Asia

Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in ROW

Exhibit 41: Key leading countries

Exhibit 42: Market opportunity

Exhibit 43: Impact of drivers and challenges

Exhibit 44: Vendor landscape

Exhibit 45: Landscape disruption

Exhibit 46: Vendors covered

Exhibit 47: Vendor classification

Exhibit 48: Market positioning of vendors

Exhibit 49: Bristol-Myers Squibb Co. – Vendor overview

Exhibit 50: Bristol-Myers Squibb Co. – Business segments

Exhibit 51: Bristol-Myers Squibb Co. – Organizational developments

Exhibit 52: Bristol-Myers Squibb Co. – Geographic focus

Exhibit 53: Bristol-Myers Squibb Co. – Key offerings

Exhibit 54: Bristol-Myers Squibb Co. – Key customers

Exhibit 55: Eli Lilly and Co. – Vendor overview

Exhibit 56: Eli Lilly and Co. – Business segments

Exhibit 57: Eli Lilly and Co. – Organizational developments

Exhibit 58: Eli Lilly and Co. – Geographic focus

Exhibit 59: Eli Lilly and Co. – Segment focus

Exhibit 60: Eli Lilly and Co. – Key offerings

Exhibit 61: Eli Lilly and Co. – Key customers

Exhibit 62: F. Hoffmann-La Roche Ltd. – Vendor overview

Exhibit 63: F. Hoffmann-La Roche Ltd. – Business segments

Exhibit 64: F. Hoffmann-La Roche Ltd. – Organizational developments

Exhibit 65: F. Hoffmann-La Roche Ltd. – Geographic focus

Exhibit 66: F. Hoffmann-La Roche Ltd. – Segment focus

Exhibit 67: F. Hoffmann-La Roche Ltd. – Key offerings

Exhibit 68: F. Hoffmann-La Roche Ltd. – Key customers

Exhibit 69: Merck & Co. Inc. – Vendor overview

Exhibit 70: Merck & Co. Inc. – Business segments

Exhibit 71: Merck & Co. Inc. – Organizational developments

Exhibit 72: Merck & Co. Inc. – Geographic focus

Exhibit 73: Merck & Co. Inc. – Segment focus

Exhibit 74: Merck & Co. Inc. – Key offerings

Exhibit 75: Merck & Co. Inc. – Key customers

Exhibit 76: Sanofi – Vendor overview

Exhibit 77: Sanofi – Business segments

Exhibit 78: Sanofi – Organizational developments

Exhibit 79: Sanofi – Geographic focus

Exhibit 80: Sanofi – Segment focus

Exhibit 81: Sanofi – Key offerings

Exhibit 82: Sanofi – Key customers

Exhibit 83: Validation techniques employed for market sizing

Exhibit 84: Definition of market positioning of vendors



【掲載企業】

Bristol-Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Merck & Co., Inc.、Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[咽頭がん治療法の世界市場:咽頭がん、喉頭がん]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆